Agenus

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.

About AGEN

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.

CEO

Garo H. Armen

CEOGaro H. Armen

Employees

316

Employees316

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

1994

Founded1994

Employees

316

Employees316

AGEN Key Statistics

Market cap

71.88M

Market cap71.88M

Price-Earnings ratio

-0.27

Price-Earnings ratio-0.27

Dividend yield

—

Dividend yield—

Average volume

1.00M

Average volume1.00M

High today

$3.40

High today$3.40

Low today

$2.84

Low today$2.84

Open price

$3.00

Open price$3.00

Volume

1.56M

Volume1.56M

52 Week high

$19.69

52 Week high$19.69

52 Week low

$1.38

52 Week low$1.38

Agenus

Why Robinhood?

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. Show more

AGEN Key Statistics

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.